Literature DB >> 25433282

Hydrogen sulfide reduces inflammation following abdominal aortic occlusion in rats.

James P Hunter1, Sarah A Hosgood2, Meeta Patel2, Peter Furness3, Robert D Sayers4, Michael L Nicholson2.   

Abstract

BACKGROUND: Remote renal ischemia-reperfusion injury (IRI) following infra-renal aortic occlusion leads to acute kidney injury and systemic inflammation. Hydrogen sulfide is a mediator of IRI and can ameliorate tissue injury in many organ systems. Its role in vascular surgery has yet to be established. We assessed the role of hydrogen sulfide in a rodent model of aortic occlusion.
METHODS: Wistar rats were divided into sham, control, and treatment groups (n = 6). Inflammation was assessed using a nonrecovery protocol. The infra-renal aorta was cross-clamped for 60 min and animals were reperfused for 120 min. Ten minutes before clamp release, treatment animals received hydrogen sulfide (10, 30, or 50 μg/kg) and control animals received 0.9% saline injected into the retroperitoneum. Renal injury and histology were assessed by a recovery protocol. The procedure was identical to the nonrecovery arm but with a single dose of hydrogen sulfide (30 μg/kg) and animals were recovered for 7 days.
RESULTS: There was no difference in animal weight between the groups (P = 0.337). In the nonrecovery arm, there was a reduction in serum levels of tumor necrosis factor alpha in sulfide-treated animals compared with controls (909 ± 98 vs. 607 ± 159 pg/mL; P = 0.0038). There was also a reduction in myeloperoxidase-positive cells in renal tissue in the sulfide-treated animals compared with controls (8 ± 4 vs. 17 ± 9; P = 0.03). There was no difference in histological injury score or endothelin-1 levels. In the recovery arm, there was no difference in renal function, Kidney Injury Molecule-1 levels, or histological injury scores.
CONCLUSION: Hydrogen sulfide has systemic and renal anti-inflammatory effects in remote IRI following aortic occlusion in rats.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25433282     DOI: 10.1016/j.avsg.2014.11.002

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  5 in total

1.  Mesenchymal stem cells promote mesenteric vasodilation through hydrogen sulfide and endothelial nitric oxide.

Authors:  Jan Te Winkel; Quincy E John; Brian D Hosfield; Natalie A Drucker; Amitava Das; Ken R Olson; Troy A Markel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-07-25       Impact factor: 4.052

2.  Role of thiosulfate in hydrogen sulfide-dependent redox signaling in endothelial cells.

Authors:  Anna Leskova; Sibile Pardue; John D Glawe; Christopher G Kevil; Xinggui Shen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-05-26       Impact factor: 4.733

3.  Stem Cell Therapy and Hydrogen Sulfide: Conventional or Nonconventional Mechanisms of Action?

Authors:  Amanda R Jensen; Natalie A Drucker; Ken R Olson; Troy A Markel
Journal:  Shock       Date:  2020-06       Impact factor: 3.533

Review 4.  Mechanisms by which hydrogen sulfide attenuates muscle function following ischemia-reperfusion injury: effects on Akt signaling, mitochondrial function, and apoptosis.

Authors:  Michael D Wetzel; Joseph C Wenke
Journal:  J Transl Med       Date:  2019-01-21       Impact factor: 5.531

5.  Periprocedural Hydrogen Sulfide Therapy Improves Vascular Remodeling and Attenuates Vein Graft Disease.

Authors:  Peter Kip; Ming Tao; Kaspar M Trocha; Michael R MacArthur; Hendrika A B Peters; Sarah J Mitchell; Charlotte G Mann; Thijs J Sluiter; Jonathan Jung; Suzannah Patterson; Paul H A Quax; Margreet R de Vries; James R Mitchell; C Keith Ozaki
Journal:  J Am Heart Assoc       Date:  2020-11-04       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.